Beit Jala Pharmaceutical Co Public Shareholding Co Sustainability Reports
Beit Jala Pharmaceutical Company manufactures, markets, and distributes generic pharmaceutical products, including solid, liquid, semi-solid, and sterile preparations. It serves both domestic and export markets with consumer healthcare and ethical medications.
Sector: Manufacturing
Country: Palestine
Exchange: Palestine Exchange
FIGI: BBG009T3KYH7
5 reports from 2022 to 2025
- Beit Jala Pharmaceutical Co Public Shareholding Co 2025 Annual Report
- Beit Jala Pharmaceutical Co Public Shareholding Co 2024 Annual Report
- Beit Jala Pharmaceutical Co Public Shareholding Co 2023 Annual Report
- Beit Jala Pharmaceutical Co Public Shareholding Co 2023 Independent Auditor's Report and Financial Statements
- Beit Jala Pharmaceutical Co Public Shareholding Co 2022 Financial Statements